Last SFr.80.55 CHF
Change Today +0.90 / 1.13%
Volume 2.9M
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 11:43 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Verena A. Briner M.D.

Director and Member of Risk Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 2 different industries.

See Board Relationships
63SFr.368,825

Background*

Dr. Verena A. Briner, MD serves as Professor of Internal Medicine at the University of Basel and Chief Medical Officer & Head of the Department of Medicine of the Lucerne Cantonal Hospital, Switzerland. Dr. Briner serves as Director of Novartis International AG. She has been a Director of Novartis AG since 2013. She is member of several medical and ethical institutions and commissions, including the Board of the Foundation for the Development of Internal Medicine in ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Director
2013-Present
Director and Member of Risk Committee

Education*

MD 1978
Universität Basel

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationSFr.193,782
Total Calculated CompensationSFr.368,825
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.80.55 CHF +0.90

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.